enVVeno Medical Corp
NVNO- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001661053
In the last 90 days, enVVeno Medical Corp insiders filed 0 open-market purchases and 1 sale; 17 institutions reported holding it in 13F filings for Q2 2026, worth $953.6K in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in enVVeno Medical Corp as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- +1 vs. Q2 2023
- Shares held
- 1.93M
- +14.6K (+0.8%) vs. Q2 2023
- Total value
- $10.4M
- +$4.51M (+76.3%) vs. Q2 2023
- New holders
- 4
- 6 more added
- Sold out
- 3
- 6 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NVNO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $953.6K |
| Q1 2026 | 17 | $1.02M |
| Q4 2025 | 36 | $2.10M |
| Q3 2025 | 36 | $5.40M |
| Q2 2025 | 37 | $20.3M |
| Q1 2025 | 31 | $9.61M |
| Q4 2024 | 35 | $12.9M |
| Q3 2024 | 36 | $17.5M |
| Q2 2024 | 26 | $17.3M |
| Q1 2024 | 32 | $19.8M |
| Q4 2023 | 30 | $21.8M |
| Q3 2023 | 24 | $10.4M |
| Q2 2023 | 23 | $5.90M |
| Q1 2023 | 18 | $8.50M |
| Q4 2022 | 22 | $8.46M |
| Q3 2022 | 22 | $13.7M |
| Q2 2022 | 21 | $8.11M |
| Q1 2022 | 21 | $13.0M |
| Q4 2021 | 24 | $13.7M |
| Q3 2021 | 16 | $8.74M |
| Q2 2021 | 14 | $6.16M |
| Q1 2021 | 16 | $5.24M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding enVVeno Medical Corp; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 781,615 | $4.21M | 0.14% | 00.0% | Unchanged |
| Vanguard Group Inc | 335,797 | $1.81M | 0.00% | 00.0% | Unchanged |
| UBS Oconnor LLC | 226,308 | $1.22M | 0.02% | +39,494+21.1% | Added |
| Kingdon Capital Management, L.L.C. | 219,180 | $1.18M | 0.22% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 92,707 | $499.8K | 0.00% | +9,624+11.6% | Added |
| Susquehanna International Group, LLP | 59,026 | $318.1K | 0.00% | −5,222−8.1% | Reduced |
| Morgan Stanley | 43,314 | $233.5K | 0.00% | +6,328+17.1% | Added |
| BlackRock Inc. | 31,079 | $167.5K | 0.00% | −2,624−7.8% | Reduced |
| State Street Corp | 26,600 | $143.4K | 0.00% | +5,100+23.7% | Added |
| Dimensional Fund Advisors LP | 18,309 | $98.7K | 0.00% | +40.0% | Added |
| Simplex Trading, LLC | 17,753 | $95.0K | 0.00% | +17,753 | New |
| Northern Trust Corp | 17,074 | $92.0K | 0.00% | 00.0% | Unchanged |
| Arthur M. Cohen & Associates, LLC | 14,000 | $75.5K | 0.02% | 00.0% | Unchanged |
| Tamar Securities, LLC | 13,990 | $75.4K | 0.02% | 00.0% | Unchanged |
| Fermata Advisors, LLC | 11,850 | $63.9K | 0.02% | +11,850 | New |
| Advisor Group Holdings, Inc. | 11,350 | $61.2K | 0.00% | −65−0.6% | Reduced |
| Group One Trading, L.P. | 6,370 | $34.3K | 0.00% | +6,370 | New |
| Financial Perspectives, Inc | 3,278 | $17.7K | 0.01% | 00.0% | Unchanged |
| Wells Fargo & Company | 2,063 | $11.1K | 0.00% | +10.0% | Added |
| Tower Research Capital LLC (TRC) | 21 | $113 | 0.00% | −3,202−99.3% | Reduced |
| Newbridge Financial Services Group, Inc. | 20 | $108 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 11 | $59 | 0.00% | +11 | New |
| UBS Group AG | 1 | $5 | 0.00% | −670−99.9% | Reduced |
| Royal Bank of Canada | 45 | $0 | 0.00% | −47−51.1% | Reduced |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −45,086−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −13,291−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −11,745−100.0% | Sold out |